SWEET VIDEO:
Self-isolating with someone who has Alzheimer’s can be hard. See the wonderful thing Tommy is doing with his Nan.
SOURCE:
SWEET VIDEO:
Self-isolating with someone who has Alzheimer’s can be hard. See the wonderful thing Tommy is doing with his Nan.
SOURCE:






This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To

The EMA has announced its schedule for reviewing the Alzheimer’s drug Leqembi (lecanemab) for use in Europe. Meanwhile, the U.S. FDA, which already approved the drug, is moving ahead with a new version that doses Leqembi in a better, more convenient fashion for those taking the drug over the long run.

“60 Minutes” interviews American neurosurgeon Dr. Ali Rezai. He is pioneering a new way to treat Alzheimer’s, focusing beams of ultrasound on the brain.

FACT SHEET: Several Alzheimer’s prescription drugs are currently approved by the U.S. Food and Drug Administration (FDA) to treat people who have been diagnosed. Learn

Immune cells work to remove toxic compounds that build up in the brain, including amyloid beta plaques associated with Alzheimer’s, according to a mouse study funded by the National Institutes of Health.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On